Brown Dennis M 4/A
4/A · Kintara Therapeutics, Inc. · Filed Sep 24, 2020
Insider Transaction Report
Form 4/AAmended
Brown Dennis M
DirectorChief Scientific Officer10% Owner
Transactions
- Award
Options (Right to Buy)
2019-11-12+250,000→ 250,000 totalExercise: $0.73Exp: 2029-11-12→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This amendment is being filed to update the vesting schedule of the option award made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 1/6th of the options vested on March 22, 2021, with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 22, 2021.